direct meds glp 1 GLP-1 Program Report 2026: Compounded Semaglutide and Tirzepatide Pricing, Telehealth Access, and Consumer Verification Factors GLP-1 Medications for Weight Loss

(27) Chang et al

Pharmacies face a profitless boom

NICE has appraised its use within specialist weight management services, subject to BMI and eligibility criteria [12] Liraglutide (Saxenda) another licensed GLP-1 receptor agonist available for weight management in adults, subject to MHRA-approved indications and prescribing criteria Orlistat (Xenical/Alli) a lipase inhibitor available on NHS prescription and, at lower dose, over the counter Tirzepatide (Zepbound) a dual GIP/GLP-1 receptor agonist authorised by the MHRA specifically for chronic weight management in adults

Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions

How much weight loss is significant

In rabbits, but not rats, there was a statistically insignificant higher number of post-implantation losses at the highest dose tested (600 mg / kg per day) than in the control group